Prima, a purpose-driven brand focused on efficacy-driven and science-backed plant therapeutics and cannabinoids, today announced the close of a $9.2M Seed Plus financing led by leading institutional […]
Alife Health Aims To Improve IVF Outcomes With $9.5M Seed
Investors infused $9.5 million of seed funding into fertility technology company Alife Health, which is building a modern operating system for in vitro fertilization (IVF) designed […]
Cellares Secures $82M Series B To Address Cell Therapy Manufacturing Obstacles
Life sciences technology company Cellares Corp. raised $82 million in Series B funding to continue developing its manufacturing tools so that cell therapy treatments can be […]
Mimicking A Hospital At Home: Huma Brings In $130M Series C
Huma Therapeutics is creating digital “hospitals at home” across different disease areas so that the pharmaceutical and research industries can run decentralized clinical trials. “Our mission […]
Interline Therapeutics Inks $92M For Drug Discovery
Interline Therapeutics launched its company Thursday following the raise of $92 million in total funding to support the company’s mission to map and correct dysfunctional protein communities. […]
Clearing Targets Chronic Pain With $20M Seed
New York-based Clearing is developing a health care technology platform for chronic pain sufferers to manage their treatments. The company closed on more than $20 million in […]
